Product Overview
AICAR 50 mg contains 5-Aminoimidazole-4-Carboxamide Ribonucleotide (Acadesine), a research compound known for its ability to activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance.
Manufactured by Dragon Pharma, AICAR is widely studied for its potential effects on fat metabolism, endurance, and glucose regulation, often referred to as an "exercise mimetic" in scientific literature.
Drug Class
AICAR belongs to the class of metabolic modulators and AMPK activators, compounds that influence cellular energy pathways and metabolic efficiency.
Indications
Primary Uses (Research Context)
- Metabolic regulation studies
- Fat loss and obesity research
- Endurance and performance research
Secondary Uses
- Glucose metabolism studies
- Insulin sensitivity research
- Cardiovascular and mitochondrial function studies
Mechanism of Action
AICAR exerts its effects by activating AMPK, a central energy sensor in the body:
- Increases fatty acid oxidation
- Enhances glucose uptake in muscle cells
- Inhibits lipid synthesis
- Mimics the metabolic effects of exercise
Activation of AMPK shifts the body toward energy utilization and improved metabolic efficiency.
Dosage & Administration
- Typical research dosing: Protocol-dependent
- Commonly administered via subcutaneous injection
- Cycle length varies based on study design
Note: AICAR is not approved for general medical use; dosing is not standardized.
Pharmacokinetics
- Rapid cellular uptake
- Short half-life requiring repeated administration in studies
- Metabolized intracellularly into active AMP analogs
Effects & Benefits
- Enhanced fat metabolism
- Improved endurance capacity
- Increased glucose utilization
- Potential reduction in body fat stores
Synergy & Stacking
AICAR is often explored in combination with other metabolic and performance-enhancing agents in research or advanced protocols:
- Cardarine (GW-501516): Enhances endurance and fatty acid oxidation
- Growth hormone (GH): Supports fat metabolism and recovery
- L-Carnitine: Assists in fatty acid transport into mitochondria
- Caloric control and exercise: Maximizes AMPK activation and fat loss outcomes
Stacking should be approached cautiously due to limited long-term human data.
Use in Special Populations
Not approved for human therapeutic use. Its safety and efficacy in humans are not fully established, and it should be limited to controlled research environments.
Pre-Use Considerations
- Assessment of metabolic health
- Blood glucose monitoring
- Evaluation of cardiovascular markers
Effectiveness
Preclinical studies suggest that AICAR can significantly enhance endurance and fat metabolism, with some research demonstrating effects comparable to prolonged exercise training.
Risk Management
Common Observations
- Fatigue
- Mild gastrointestinal discomfort
Potential Side Effects
- Hypoglycemia (low blood sugar)
- Headaches
- Injection site irritation
Serious Concerns
- Cardiovascular stress (in high doses)
- Unknown long-term safety profile
Mitigation Strategies
- Monitor blood glucose levels
- Use within controlled research parameters
- Avoid excessive dosing
Post-Use Considerations
- Monitor metabolic markers
- Maintain balanced nutrition
- Evaluate endurance and body composition changes
What to Avoid While Using AICAR
- Fasting without monitoring (risk of hypoglycemia)
- Combining with unverified metabolic agents
- Ignoring hydration and nutrient intake
Drug Interactions
- Glucose-lowering agents (may enhance effects)
- Other metabolic modulators
- Cardiovascular medications
Conclusion
AICAR 50 mg (Acadesine) is a powerful metabolic research compound with the ability to activate AMPK and mimic exercise-like effects on fat metabolism and endurance. Due to its experimental status, it should be used cautiously and within scientific or controlled environments.
What is the peptide AICAR used for?
AICAR is used in research to study fat metabolism, endurance enhancement, and glucose regulation through AMPK activation.
What are the side effects of AICAR?
Potential side effects include fatigue, low blood sugar, headaches, and injection site irritation, with limited long-term safety data.
How does AICAR compare to exercise?
AICAR activates AMPK similarly to exercise, promoting fat burning and improved endurance, which is why it is often called an "exercise mimetic."
Does AMPK reduce belly fat?
AMPK activation promotes fat oxidation and may contribute to reduction in body fat, including abdominal fat, when combined with proper diet and activity.
